Journal of International Oncology››2014,Vol. 41››Issue (11): 805-807.doi:10.3760/cma.j.issn.1673422X.2014.11.002
Previous ArticlesNext Articles
WANG Huan-Sheng, LI Pang, LI Sheng
Online:
2014-12-03Published:
2015-01-20Contact:
Li Sheng, Email: drlisheng@sohu.comWANG Huan-Sheng, LI Pang, LI Sheng. Establishment of circulating tumor cell linesWang[J]. Journal of International Oncology, 2014, 41(11): 805-807.
[1] Ilina O, Friedl P. Mechanisms of collective cell migration at a glance[J]. Cell Sci, 2009, 122(Pt 18):32033208. [2] Thompson EW, Haviv I. The social aspects of EMTMET plasticity[J]. Nat Med, 2011, 17(9):10481049. [3] Hao J, Zhang Y, Deng M, et al. MicroRNA control of epithelialmesenchymal transition in cancer stem cells[J]. Int J Cancer, 2014, 135(5):10191027. [4] Cowin P, Wysolmerski J. Molecular mechanisms guiding embryonic mammary gland development[J]. Cold Spring Harb Perspect Biol, 2010, 2(6):a003251. [5] Hou JM, Krebs M, Ward T, et al. Circulating tumor cells as a window on metastasis biology in lung cancer[J]. Am Pathol, 2011, 178(3):989996. [6] Kallergi G, Papadaki MA, Politaki E, et al. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients[J]. Breast Cancer Res, 2011, 13(3):R59. [7] Kallergi G, Konstantinidis G, Markomanolaki H, et al. Apoptotic circulating tumor cells in early and metastatic breast cancer patients[J]. Mol Cancer Ther, 2013, 12(9):18861895. [8] Bonnomet A, Brysse A, Tachsidis A, et al. Epithelialtomesenchymal transitions and circulating tumor cells[J]. Mammary Gland Biol Neoplasia, 2010, 15(2):261273. [9] Dondossola E, Rangel R, GuzmanRojas L, et al. CD13positive bone marrowderived myeloid cells promote angiogenesis, tumor growth, and metastasis[J]. Proc Natl Acad Sci USA, 2013, 110(51):2071720722. [10] Shaked Y, McAllister S, Fainaru O, et al. Tumor dormancy and the angiogenic switch: possible implications of bone marrowderived cells[J]. Curr Pharm Des, 2014, 20(30):49204933. [11] Fan Q, Gu D, Liu H, et al. Defective TGFbeta signaling in bone marrowderived cells prevents hedgehoginduced skin tumors[J]. Cancer Res, 2014, 74(2):471483. [12] Peinado H, Aleckovic M, Lavotshkin S, et al.Melanoma exosomes educate bone marrow progenitor cells toward a prometastatic phenotype through MET[J]. Nat Med, 2012; 18(6):883891. [13] Kumar S, Park SH, Cieply B, et al. A pathway for the control of anoikis sensitivity by Ecadherin and epithelialtomesenchymal transition[J]. Mol Cell Biol, 2011, 31(19):40364051. [14] Park SH, Riley P 4th, Frisch SM. Regulation of anoikis by deleted in breast cancer1 (DBC1) through NFkappaB[J]. Apoptosis, 2013, 18(8):949962. [15] Yao X, Choudhury AD, Yamanaka YJ, et al. Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits[J]. Integr Biol (Camb), 2014, 6(4):388398. [16] 周开华, 陈晓丹, 宋鑫. 恶性胸水培养肿瘤细胞失败原因分析[J]. 昆明医学院学报, 2011, 32(5):4749,57. [17] Desitter I, Guerrouahen BS, BenaliFuret N, et al. A new device for rapid isolation by size and characterization of rare circulating tumor cells[J]. Anticancer Res, 2011, 31(2):427441. [18] Lin HK, Zheng S, Williams AJ, et al. Portable filterbased microdevice for detection and characterization of circulating tumor cells[J]. Clin Cancer Res, 2010, 16(20):50115018. [19] Hou JM, Krebs MG, Lancashire L, et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with smallcell lung cancer[J]. J Clin Oncol, 2012, 30(5):525532. [20] Stott SL, Hsu CH, Tsukrov DI, et al. Isolation of circulating tumor cells using a microvortexgenerating herringbonechip[J]. Proc Natl Acad Sci USA, 2010, 107(43):1839218397. [21] Zheng S, Lin HK, Lu B, et al. 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood[J]. Biomed Microdevices, 2011, 13(1):203213. [22] Krebs MG, Hou JM, Sloane R, et al.Analysis of circulating tumor cells in patients with nonsmall cell lung cancer using epithelial markerdependent and independent approaches[J]. Thorac Oncol, 2012, 7(2):306315. [23] Ma YC, Wang L, Yu FL, et al. Recent advances and prospects in the isolation by size of epithelial tumor cells (ISET) methodology[J]. Technol Cancer Res Treat, 2013, 12(4):295309. [24] Tinhofer I, Saki M, Niehr F, et al. Cancer stem cell characteristics of circulating tumor cells[J]. Int J Radiat Biol, 2014, 90(8):622627. |
[1] | Chen Luojun, Li Na, Tian Jingyuan, Song Qibin, Yu Jinming.Progress of circulating tumor cells in clinical application[J]. Journal of International Oncology, 2018, 45(8): 552-555. |
[2] | Li Zhijian, He De.Research progress on liquid biopsy in pancreatic cancer[J]. Journal of International Oncology, 2018, 45(3): 180-182. |
[3] | ZOU Jiang, GUO Xiao-Lan.Advances of liquid biopsy in the diagnosis and treatment of tumor[J]. Journal of International Oncology, 2018, 45(2): 107-111. |
[4] | Yu Huajie*, Han Lu, Ou Yang, Li Sheng, Gao Dehai.Application of fluorescence in the identification of circulating tumor cells[J]. Journal of International Oncology, 2018, 45(1): 35-. |
[5] | Feng Fei, Qin Songbing.Application of threedimensional cell culture model in cancer research[J]. Journal of International Oncology, 2015, 42(7): 532-534. |
[6] | Ni-Ting, WANG Yu-Dong.Dissemination, detection and clinical use of circulating tumor cell[J]. Journal of International Oncology, 2015, 42(11): 841-844. |
[7] | Gao Yang, Yuan Zhou.Research progress of nanotechnology in circulating tumor cell[J]. Journal of International Oncology, 2015, 42(1): 46-48. |
[8] | XING Zhen-Yu, ZHANG Hui-Di, GAO Lei, CHANG Wen-Long, TIAN Shao-Hui, ZHANG Hui.Effect of disodium cantharidinate on in vitro lymphocyte immune response in lung cancer patients[J]. Journal of International Oncology, 2014, 41(11): 862-865. |
[9] | XIA Fan, ZHAO Teng, WANG Yan.Detection technique of circulating tumour cells in lung cancer[J]. Journal of International Oncology, 2012, 39(7): 523-525. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||